Three AI deals kick off #JPM22 week­end; Can Sil­i­con Val­ley change how sci­ence gets fund­ed?; Spe­cial re­port: 2021 new drug ap­provals; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

A no­table trend in this week’s in­stall­ment of news is a hearty plate of ap­pe­tiz­er-sized deals as we lead in­to the JP Mor­gan con­fer­ence. As per End­points tra­di­tion, we have sched­uled three days of vir­tu­al pan­els fea­tur­ing an ex­cel­lent line­up of bio­phar­ma in­sid­ers to talk about the top trends they will be watch­ing in 2022. You don’t want to miss it.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.